IRF3 and gastric cancer: Analysis of the TCGA study revealed higher expression of the IRF3 signature in EBV (+) GC than in CIN or gnomically stable (GS) cases, and a significant positive correlation with the IFN-γ signature in EBV (+) GC (Fig. 3e).